(Total Views: 415)
Posted On: 10/09/2024 9:24:54 PM
Post# of 154882
Not sure if he was ever employed by Madrigal other than as a presenter. But was participating for multiple years. And currently on our SAB. That’s a good thing.
HIV
MASH
CANCER
INFLAMNATION
PUBLUCATIONS
And the beat goes on…
“Mazes Noureddin, MD, MHSc is a doctor and industry presenter for Madrigal Pharmaceuticals, Inc.:
Role
Noureddin is the Director of the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai Medical Center. He has presented at Madrigal events, including a 2021 virtual product theater presentation on NASH with fibrosis. He also presented at The Liver Meeting in 2024 on Rezdiffra (resmetirom), a treatment option for patients.
Conflicts of interest
Noureddin is on the advisory board for Madrigal, as well as other companies. He is also a stockholder in Rivus Pharma, Cytodyn, and ChronWell.”
HIV
MASH
CANCER
INFLAMNATION
PUBLUCATIONS
And the beat goes on…
“Mazes Noureddin, MD, MHSc is a doctor and industry presenter for Madrigal Pharmaceuticals, Inc.:
Role
Noureddin is the Director of the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai Medical Center. He has presented at Madrigal events, including a 2021 virtual product theater presentation on NASH with fibrosis. He also presented at The Liver Meeting in 2024 on Rezdiffra (resmetirom), a treatment option for patients.
Conflicts of interest
Noureddin is on the advisory board for Madrigal, as well as other companies. He is also a stockholder in Rivus Pharma, Cytodyn, and ChronWell.”
(2)
(0)
